How were Diffusion Pharmaceuticals' earnings last quarter?

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($9.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.00) by $6.00.

When did Diffusion Pharmaceuticals' stock split?

Diffusion Pharmaceuticals shares reverse split on Thursday, August 17th 2023. The 1-1.5 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 67 shares after the split.

What other stocks do shareholders of Diffusion Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Diffusion Pharmaceuticals investors own include Matinas BioPharma (MTNB) , Bionano Genomics (BNGO) , ADMA Biologics (ADMA) , Novan (NOVN) , Zosano Pharma (ZSAN) , Gran Tierra Energy (GTE) , Cogent Biosciences (UMRX) , Aeterna Zentaris (AEZS) , Sorrento Therapeutics (SRNE) and Enerplus (ERF) .

NASDAQ:DFFN

Diffusion Pharmaceuticals (DFFN) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free DFFN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $4.38
▼
$6.60
52-Week Range: N/A

Volume: 351,000 shs
Average Volume: 10,937 shs
Market Capitalization: $8.98 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Diffusion Pharmaceuticals alerts:

Ad Crypto Swap Profits

He Is Giving Away Bitcoin

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Diffusion Pharmaceuticals Stock (NASDAQ:DFFN)

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.

Ad Crypto Swap Profits

He Is Giving Away Bitcoin

>> Register right here

DFFN Stock News Headlines

February 10, 2024 | thestreet.com

Diffusion Pharmaceuticals Inc.

February 8, 2024 | bizjournals.com

Vertex co-founder Josh Boger joins Boston biotech working on dementia drug

April 16, 2024 | Crypto Swap Profits (Ad)

He Is Giving Away Bitcoin

December 22, 2023 | venturebeat.com

Stable Video Diffusion is now available through Stability AI API

August 16, 2023 | finanznachrichten.de

Diffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma

August 16, 2023 | finanznachrichten.de

Diffusion Pharmaceuticals Inc.: Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma / Announces 1-for-1.5 Reverse Stock Split

August 15, 2023 | finance.yahoo.com

Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma

July 24, 2023 | finance.yahoo.com

Diffusion Pharmaceuticals Inc. (DFFN) stock forecast and price target

April 16, 2024 | Crypto Swap Profits (Ad)

He Is Giving Away Bitcoin

May 23, 2023 | benzinga.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFN

March 31, 2023 | marketwatch.com

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Diffusion Pharmaceuticals Inc. Merger

March 30, 2023 | technews.tmcnet.com

DFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to Shareholders

March 30, 2023 | msn.com

Diffusion to merge with EIP Pharma in all-stock deal

March 30, 2023 | finance.yahoo.com

EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases

December 16, 2022 | markets.businessinsider.com

Diffusion's Shareholder LifeSci Supports Company's Strategic Review Process And Director Nominees

December 16, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities

December 5, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealing

December 1, 2022 | finance.yahoo.com

DFFN: Strategic Review Underway; Planning to Initiate Phase 2 GBM Trial in 1Q23…

November 15, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

November 14, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process

October 15, 2022 | forbes.com

Diffusion Pharmaceuticals

September 29, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals Inc. (DFFN)

August 17, 2022 | seekingalpha.com

Diffusion raised to Buy at H.C. Wainwright after Q2 update on lead asset

August 17, 2022 | finance.yahoo.com

DFFN: Phase 2 GBM Trial to Initiate 2H22…

August 11, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

July 26, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation

June 23, 2022 | finance.yahoo.com

Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial

See More Headlines

Receive DFFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diffusion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/10/2021
Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:DFFN
CUSIP: N/A
CIK: 1053691
Web: www.diffusionpharma.com
Phone: (434) 220-0718
Fax: 434-220-0722
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-15,590,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -69.96%
Return on Assets: -62.98%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 10.71
Quick Ratio: 10.71

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $6.97 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 2,040,000
Free Float: 2,003,000
Market Cap: $8.98 million
Optionable: Not Optionable
Beta: 1.78

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Robert J. Cobuzzi Jr. (Age 58)
Ph.D., Pres & CEO
Comp: $691.79k
Mr. William Robert Elder J.D. (Age 40)
Gen. Counsel & Corp. Sec.
Comp: $413.92k
Dr. David Randolph Jones M.D. (Age 60)
Sr. Medical Advisor
Mr. Harry Cook
VP of Clinical Operations
Mr. Douglas Gravatt
Sr. Consultant for Manufacturing
Mr. Brian D. Bollwage
Sr. Consultant - Regulatory Affairs

Key Competitors

View All Competitors

DFFN Stock Analysis - Frequently Asked Questions

How were Diffusion Pharmaceuticals' earnings last quarter?: Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($9.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.00) by $6.00.
When did Diffusion Pharmaceuticals' stock split?: Diffusion Pharmaceuticals shares reverse split on Thursday, August 17th 2023. The 1-1.5 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 67 shares after the split.
What other stocks do shareholders of Diffusion Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Diffusion Pharmaceuticals investors own include Matinas BioPharma (MTNB), Bionano Genomics (BNGO), ADMA Biologics (ADMA), Novan (NOVN), Zosano Pharma (ZSAN), Gran Tierra Energy (GTE), Cogent Biosciences (UMRX), Aeterna Zentaris (AEZS), Sorrento Therapeutics (SRNE) and Enerplus (ERF).

This page (NASDAQ:DFFN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Diffusion Pharmaceuticals (DFFN) Stock Price, News & Analysis

About Diffusion Pharmaceuticals Stock (NASDAQ:DFFN)

DFFN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

DFFN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info